LJ's E-Smokes LLC
Letter data
- Company
- LJ's E-Smokes LLC
- Recipient
- Henry Williams | LJ's E-Smokes LLC | United States | support@ljesmokes.com | henry@ljesmokes.com
- Issue date
- 2022-05-27
- Posted date
- Not available
- FDA office
- Center for Tobacco Products
- Subject
- Not available
- Product
- Tobacco
- CMS ID
- 614221
- Reference number
- RW2101573
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: 21-CFR-PART-114021-CFR-PART-1141
21 U.S.C.: 21-USC-301
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
LJ's E-Smokes LLC
MARCS-CMS 614221 —
May 27, 2022
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
VIA Electronic Mail
Reference #:
RW2101573
Product:
Tobacco
Recipient:
Recipient Name
Henry Williams
LJ's E-Smokes LLC
United States
support@ljesmokes.com
henry@ljesmokes.com
Issuing Office:
Center for Tobacco Products
United States
Dear Henry Williams:
The United States Food and Drug Administration’s (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions included in your responses dated April 27, 2021 and May 13, 2021 to our Warning Letter dated April 9, 2021. Based on our evaluation, it appears that you have taken steps to address the violations contained in the Warning Letter regarding your website http://www.ljesmokes.com.
However, our surveillance shows you continue to offer for sale to customers in the United States other tobacco products that may be subject to market authorization requirements. FDA encourages you to discuss with your suppliers the current status of any particular tobacco product’s marketing application or authorization. For additional information regarding the marketing status of tobacco products that a company generally might manufacture, distribute, or sell, please visit our website https://www.fda.gov/tobacco-products/market-and-distribute-tobacco-product/deemed-new-tobacco-product-applications-lists?utm_medium=email&utm_source=govdelivery#list%20of%20deemed
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure sustained compliance with each applicable provision of the Federal Food, Drug, and Cosmetic Act (FD&C Act) and FDA’s implementing regulations or with other relevant legal authority. Please note that if your firm is found to be in violation of the FD&C Act, 21 U.S.C. § 301 et seq., Chapter IX, relating to tobacco products including the tobacco regulations in 21 C.F.R. Parts 1140, 1141, and 1143 in the future, this may lead to regulatory action, including, but not limited to, civil money penalties, seizure, and/or injunction.
Sincerely,
/S/
David Rice
Branch Chief
Division of Promotion, Advertising, and Labeling
Office of Compliance and Enforcement
Center for Tobacco Products
VIA Electronic Mail
cc:
Contact Privacy, Inc. Customer 0146209974
ljesmokes.com@contactprivacy.com
Tucows Domains Inc.
domainabuse@tucows.com
InMotion Hosting, Inc.
abuse@inmotionhosting.com
Content current as of:
06/08/2022
Regulated Product(s)
Tobacco